Frelii, Inc. (OTC: FRLI) Developing personalized medicine using DNA big data & AI

July 9, 2019 admin CEO Interview, Healthcare Comments Off on Frelii, Inc. (OTC: FRLI) Developing personalized medicine using DNA big data & AI

 

 

Ian Jenkins, CEO

 

 

 

 

 

 

 

Frelii, Inc. (OTC: FRLI), interview with CEO Ian Jenkins discussing the company’s personalized medicine technology which uses human DNA gene sequencing and artificial intelligence (AI) to assess more than 3.2 billion markers on the human genome.

 Ian explains how Frelii is starting to commercialize it’s technology with initial applications in medical cannabis, and psychotropic medicines. 

 

 

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.




Related Articles

Newsmakers

Medicine Man Technologies (OTC: MDCL) Highlights Landmark Consolidation Strategy To Create One Of North America’s Largest Vertically Integrated Cannabis Operators. Projected Annual Revenues From The Previously Disclosed Proposed Acquisitions Total Approximately $170 Million In 2019

September 16, 2019 admin Newsmakers Comments Off on Medicine Man Technologies (OTC: MDCL) Highlights Landmark Consolidation Strategy To Create One Of North America’s Largest Vertically Integrated Cannabis Operators. Projected Annual Revenues From The Previously Disclosed Proposed Acquisitions Total Approximately $170 Million In 2019

DENVER, Sept. 16, 2019 — Medicine Man Technologies, Inc. (OTC: MDCL) (“Medicine Man Technologies” or the “Company”) announced a culmination of its roll-up strategy today that would solidify the Company as one of the largest vertically integrated cannabis […]